1-9 of 9
Francesco d'Amore, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Molecular Profiling of Aggressive Non-Hodgkin Lymphoma - Results from a Phase 1/2 Preben Study

Suvi-Katri Leivonen, PhD, Judit Jørgensen, MD PhD, Thomas Stauffer Larsen, MD PhD, Annika Pasanen, MD PhD, Marja-Liisa Karjalainen-Lindsberg, MD PhD, Helle M Toldbod, PhD, Francesco d'Amore, MD PhD, Sirpa Leppa, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5314.
https://doi.org/10.1182/blood-2019-129113
Published: 2019
Journal Articles

Elevated Pre-Therapeutic Serum Levels of Soluble Programmed Death 1 Protein (sPD-1) Identify DLBCL Patients with Adverse Prognostic Features

Julie Bondgaard Mortensen, MS, Ida Monrad Hansen, B.Sc., Michael Roost Clausen, MD, Mette Bjerre, M.Sc.PhD, Francesco d'Amore, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4148.
https://doi.org/10.1182/blood.V130.Suppl_1.4148.4148
Published: 2017
Journal Articles

High Intratumoral Galectin-1 Is Associated with Adverse Outcome in ALK-Negative, CD30-Positive Peripheral T-Cell Lymphomas

Johanne Marie Holst, MD, Maja Ludvigsen, MSc, PhD Ass.prof, Stephen Dutoit, Knud Bendix, Trine Lindhardt Plesner, Peter Noergaard, MD, Michael Boe Møller, Torben Steiniche, Gabriel Rabinovich, PhD, Francesco d'Amore, MD PhD, Martin Bjerregård Pedersen, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4079.
https://doi.org/10.1182/blood.V130.Suppl_1.4079.4079
Published: 2017
Journal Articles

The Impact of Upfront Autologous Transplant on the Survival of Adult Patients with ALCL and PTCL-NOS According to Their ALK , DUSP22 and TP63 Gene Rearrangement Status - a Joined Nordic Lymphoma Group and Mayo Clinic Analysis

Martin Bjerregård Pedersen, MD PhD, Thomas Relander, MD PhD, Grete Fossum Lauritzsen, PhD MD, Fredrik Ellin, MD MSc, Sirpa Leppä, MD PhD, Susanna Mannisto, MD PhD, Esa Jantunen, MD, Rhett P. Ketterling, MD, Patrick Bedroske, BS, Ivy Luoma, BA, Christopher Sattler, BS, Jan M.A. Delabie, MD PhD, Christer Sundstrom, MD, Birgitta Sander, MD PhD, Marja-Liisa Karjalainen-Lindsberg, Stephen Hamilton-Dutoit, MD, Mats Ehinger, MD PhD, M Vornanen, MD, Elisabeth Ralfkiaer, MD DMSC, Rebecca Boddicker, PhD, Nabila Nora Bennani, MD, Naoki Oishi, MD PhD, Michael Boe Moeller, Peter Noergaard, MD, James R. Cerhan, MD PhD, Matthew J Maurer, MS, Knut Liestol, Helle Toldbod, MS,PhD, Andrew L Feldman, MD, Francesco d'Amore, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 822.
https://doi.org/10.1182/blood.V130.Suppl_1.822.822
Published: 2017
Journal Articles

The Impact of Pre-Therapeutic Haemoglobin Levels on the Outcome of Patients with Diffuse Large B-Cell Lymphoma Treated with Anthracycline Containing Chemotherapy before and after the Introduction of Rituximab: A Nation-Wide Cohort Study

Michael Roost Clausen, MD, Sinna Pilgaard Ulrichsen, MSc, Thomas Stauffer Larsen, MD PhD, Bodil Himmelstrup, MD PhD, Dorthe Rønnov-Jessen, MD, Per Trøllund Pedersen, MD, Jakob Madsen, MD, Robert Schou Pedersen, MD, Pär Josefsson, MD PhD, Jette Sønderskov Gørløv, MD, Mette Nørgaard, MD PhD, Francesco d'Amore, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1566.
https://doi.org/10.1182/blood.V130.Suppl_1.1566.1566
Published: 2017
Journal Articles

Lympho- and Myeloproliferative Malignancies Occurring in the Same Host: Description of a Nationwide Discovery Cohort

Johanne Marie Holst, MD, Trine Lindhardt Plesner, Martin Bjerregård Pedersen, MD PhD, Maja Ludvigsen, MSc, PhD Ass.prof, Henrik Frederiksen, Michael Boe Moeller, Rui Wang, Wayne Tam, MD PhD, Giorgio Inghirami, MD, Francesco d'Amore, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1525.
https://doi.org/10.1182/blood.V130.Suppl_1.1525.1525
Published: 2017
Journal Articles

The Combination of Pixantrone, Etoposide, Bendamustine and, in CD20+ Tumors, Rituximab (PREBEN) Shows Promising Feasibility/Efficacy in Heavily Pre-Treated Aggressive Lymphomas of B- and T-Cell Phenotype - Results of the Pre-Trial Experience Leading to a Nordic Phase 1/2 Study (the PREBEN Trial)

Michael Roost Clausen, MD, Sirpa Leppa, MD, Peter de Nully Brown, MD, Jette Soenderskov Goerloev, MD, Michael Panny, MD, Wolfgang Willenbacher, MD, Ida Blok Sillesen, MD, Erik Segel, MD, Hans Bentzen, MD, Michael Thorsgaard, MD, Elisa Jacobsen Pulczynski, MD, Peter Kamper, MD, Lars C. Gormsen, MD, Julie Mortensen, MDcal Student, Grethe Lauritzsen, MD, Thomas Relander, MD PhD, Francesco d'Amore, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1782.
https://doi.org/10.1182/blood.V128.22.1782.1782
Published: 2016
Journal Articles

Low Serum Galectin-1 Levels Predict Future Lymphoma Development in HIV-Positive Patients

Maja Ludvigsen, MSc PhD, Maja Ølholm Vase, MD PhD, Rikke Hjortebjerg, MSc, Irma Petruskevicius, MD, Court Pedersen, Gitte Pedersen, Betina Sørensen, Mette Bjerre, Niels Obel, Bent Honoré, Carsten Schade Larsen, Francesco d'Amore, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2945.
https://doi.org/10.1182/blood.V128.22.2945.2945
Published: 2016
Journal Articles

High Intratumoral Expression of Galectin-1 Correlates with Superior Outcome in HIV-Associated DLBCL

Maja Ludvigsen, MSc PhD, Maja Ølholm Vase, MDPhD, Knud Bendix, Stephen Hamilton-Dutoit, Gabriel A Rabinovich, PhD, Michael Boe Moeller, Court Pedersen, Gitte Pedersen, Niels Obel, Carsten Schade Larsen, Francesco d'Amore, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4142.
https://doi.org/10.1182/blood.V128.22.4142.4142
Published: 2016